RecruitingNot ApplicableNCT05673915

Study of Transcranial Direct Current Stimulation to Treat Epilepsy

Pilot Study of Transcranial Direct Current Stimulation (tDCS) to Treat Epilepsy


Sponsor

Mayo Clinic

Enrollment

30 participants

Start Date

Apr 12, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research is to see to what extent electrical stimulation applied to the scalp (transcranial direct current stimulation or tDCS) can reduce the number and intensity of epileptic seizures.


Eligibility

Min Age: 6 Years

Plain Language Summary

Simplified for easier understanding

This study tests transcranial direct current stimulation (tDCS) — a non-invasive, gentle electrical brain stimulation delivered through scalp electrodes — as a treatment to reduce seizures in children and adults with epilepsy that has not responded to at least two medications. tDCS applies a very small electrical current to targeted brain areas to reduce abnormal electrical activity. This study tracks seizure frequency before, during, and after tDCS treatment. **You may be eligible if...** - You are 6 or older - You have a clinical diagnosis of generalized or focal epilepsy, or sleep-related epileptic encephalopathy - You have at least 2 countable seizures per month, or spike-wave activity on EEG at least 50% of the time - At least 2 anti-seizure medications have not controlled your seizures - You can maintain a stable medication regimen during the study - You or your legal representative can understand English and keep a seizure diary **You may NOT be eligible if...** - You have a condition likely to progress during the study - You have psychogenic non-epileptic seizures - You have attempted suicide or been psychiatrically hospitalized in the past 2 years - You have a skin condition that prevents scalp electrode placement, or an allergy to silver - You are pregnant - You have implanted devices (except vagal nerve stimulator, which is allowed) **Talk to your neurologist if** you or your child has epilepsy that has not responded to multiple medications and you want to explore non-drug brain stimulation options.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEActivaDose II 0.1 mA transcranial direct current stimulation (tDCS)

Stimulation setting 0.1 mA daily for a 2-month period. Each daily treatment will last for approximately 30 minutes.

DEVICEActivaDose II 2.0 mA transcranial direct current stimulation (tDCS)

Stimulation setting 2.0 mA daily for a 2-month period. A Each daily treatment will last for approximately 30 minutes.


Locations(1)

Mayo Clinic Minnesota

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05673915


Related Trials